Chuanliang Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Molecular Dynamics Simulations

Structure Activity Relationship

Top Venues

Journal of medicinal chemistry

ACS pharmacology & translational science

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Chuanliang Zhang, Xianmin Yang, Lijuan Wu, Fei Liu, Kehong Dong, Chuanlong Guo, Liyan Gong, Guozhen Dong, Yiying Shi, Zongwen Gu, Xiaochun Liu, Shan Liu, Juan Wu, Feng Su
Site-Specifically Modified Peptide Inhibitors of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase with Enhanced Stability and Improved In Vivo Long-Acting Activity. ACS pharmacology & translational science 7 (5) (2024)
Chuanliang Zhang, Xianmin Yang, Lijuan Wu, Fei Liu, Kehong Dong, Chuanlong Guo, Liyan Gong, Guozhen Dong, Yiying Shi, Zongwen Gu, Xiaochun Liu, Shan Liu, Juan Wu, Feng Su
Site-Specifically Modified Peptide Inhibitors of Protein Tyrosine Phosphatase 1B and T-Cell Protein Tyrosine Phosphatase with Enhanced Stability and Improved In Vivo Long-Acting Activity. ACS pharmacology & translational science 7 (5) (2024)
Chuanliang Zhang, Xianmin Yang, Xinjia Meng, Lijuan Wu, Xiaochun Liu, Jiangming Gao, Shan Liu, Juan Wu, Dingmin Huang, Zhenwei Wang, Xianbin Su
Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues. Journal of medicinal chemistry (2023)
Chuanliang Zhang, Xianmin Yang, Xinjia Meng, Lijuan Wu, Xiaochun Liu, Jiangming Gao, Shan Liu, Juan Wu, Dingmin Huang, Zhenwei Wang, Xianbin Su
Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues. Journal of medicinal chemistry 66 (4) (2023)
Chuanliang Zhang, Xianmin Yang, Xinjia Meng, Lijuan Wu, Xiaochun Liu, Jiangming Gao, Shan Liu, Juan Wu, Dingmin Huang, Zhenwei Wang, Xianbin Su
Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues. Journal of medicinal chemistry 66 (4) (2023)
Chuanliang Zhang, Xianmin Yang, Xinjia Meng, Lijuan Wu, Xiaochun Liu, Jiangming Gao, Shan Liu, Juan Wu, Dingmin Huang, Zhenwei Wang, Xianbin Su
Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues. Journal of medicinal chemistry 66 (4) (2023)
Chuanliang Zhang, Xianmin Yang, Xinjia Meng, Lijuan Wu, Xiaochun Liu, Jiangming Gao, Shan Liu, Juan Wu, Dingmin Huang, Zhenwei Wang, Xianbin Su
Discovery of Novel PTP1B Inhibitors with Once-Weekly Therapeutic Potential for Type 2 Diabetes: Design, Synthesis, and In Vitro and In Vivo Investigations of BimBH3 Peptide Analogues. Journal of medicinal chemistry 66 (4) (2023)
Chuanliang Zhang, Lijuan Wu, Xiaochun Liu, Jiangming Gao, Shan Liu, Juan Wu, Dingmin Huang, Zhenwei Wang, Xianbin Su
Discovery of Novel PTP1B Inhibitors Derived from the BH3 Domain of Proapoptotic Bcl-2 Proteins with Antidiabetic Potency. ACS medicinal chemistry letters 12 (6) (2021)